Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (3,858,000)	$ (2,242,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	435,000	485,000
Accretion of discount on investments	(87,000)	0
Stock-based compensation	420,000	674,000
Gain on extinguishment of PPP loan	0	(1,584,000)
Changes in operating assets and liabilities:
Accounts receivable	929,000	1,263,000
Prepaid expenses and other assets	(52,000)	167,000
Contract assets	46,000	(46,000)
Third-party software fees payable	(555,000)	(1,830,000)
Accounts payable and accrued expenses	(71,000)	(275,000)
Deferred revenue	(928,000)	(978,000)
Net cash used in operating activities	(3,721,000)	(4,366,000)
Cash flows from investing activities:
Additions to property and equipment	(522,000)	(474,000)
Proceeds from maturity of short-term investments	10,750,000	0
Purchases of short-term investments	(10,670,000)	0
Net cash used in investing activities	(442,000)	(474,000)
Cash flows from financing activities:
Proceeds from sale of common stock, net of issuance fees	0	31,936,000
Proceeds from exercise of stock options	81,000	68,000
Cash settlement of performance stock units	(137,000)	0
Repurchases of common stock	(203,000)	0
Net cash (used in) provided by financing activities	(259,000)	32,004,000
Effect of exchange rates on cash	(29,000)	(38,000)
Net increase in cash, restricted cash, and cash equivalents	(4,451,000)	27,126,000
Cash, restricted cash, and cash equivalents, beginning of year	40,086,000	12,960,000
Cash, restricted cash, and cash equivalents, end of year	$ 35,635,000	$ 40,086,000